Previous close | 0.4000 |
Open | 0.4000 |
Bid | 0.9500 |
Ask | 1.2500 |
Strike | 75.00 |
Expiry date | 2024-06-21 |
Day's range | 0.4000 - 0.7200 |
Contract range | N/A |
Volume | |
Open interest | 7 |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats